A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5) - AGMT_CML 1
| Image |  |
|---|---|
| Description | scientific article published on 05 August 2020 |
| Author/s |
author: Sonja Heibl |
| Publication date | August 5, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |